OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/30/2026
Back to search
Official data from USPTO
CYCURIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/30/2026
Trademark type
Word
Nice classes
5, 42
Filing date
11/12/2024
Registration date
03/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2026
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AT
Examiner
KAPLAN, VALERIE ELIZABETH
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Cycuria Therapeutics GmbH
Cycuria GmbH
Representatives
Alisa C. Simmons Fitch Even Tabin & Flannery LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and formulationsmedicated health preparationsfor use in the treatment or prevention of human and animal diseasesdisorders and conditionsespecially circulatoryrespiratoryendocrineneurologiccardiovascularalimentarypulmonarymusculoskeletallymphatic and gastrointestinal diseasesdisorders and conditionsthe treatment or prevention of complications associated with such diseasesdisorders and conditions; pharmaceutical preparations and formulationsmedicated health preparationsfor use in the treatment or prevention of human and animal diseasesdisorders and conditionsespecially bone sensoryviralurinaryrenalmetabolic and central nervous system diseasesdisorders and conditionsthe treatment or prevention of complications associated with such diseasesdisorders and conditions; pharmaceutical preparations and formulationsmedicated health preparationsfor use in the treatment or prevention of human and animal diseasesdisorders and conditionsespecially infectiousauto-immune and immune-relatedcell-proliferative and oncologic diseasesdisorders and conditionscancerstumours and metastasesthe treatment or prevention of complications associated with such diseasesdisorders and conditions; diagnostic preparations and biomarker reagents for medical or veterinary purposes; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseasesdisorders and conditionsespecially circulatoryrespiratoryendocrineneurologiccardiovascularalimentarypulmonarymusculoskeletallymphatic and gastrointestinal diseasesdisorders and conditionsthe diagnosis and prognosis of complications associated with such diseasesdisorders and conditions; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseasesdisorders and conditionsespecially bone sensoryviralurinaryrenalmetabolic and central nervous system diseasesdisorders and conditionsthe diagnosis and prognosis of complications associated with such diseasesdisorders and conditions; diagnostic preparations and biomarker reagents for the diagnosis and prognosis of human and animal diseasesdisorders and conditionsespecially infectiousauto-immune and immune-relatedcell-proliferative and oncologic diseasesdisorders and conditionscancerstumours and metastasesthe diagnosis and prognosis of complications associated with such diseasesdisorders and conditions.
Class 42
Scientific services and research relating theretoscientific research; Scientific services and research relating theretoscientific research and development; Scientific services and research relating theretoscientific research for medical purposes in the field of cancerous diseases; Scientific services and research relating theretoscientific researchanalysistesting in the fields of genomicsgeneticsgenetic engineeringbiotechnologymedicine; Scientific services and research relating theretoproviding scientific research information in the field of genetics; Scientific services and research relating theretoproviding scientific research information in the field of pharmaceuticals; Scientific services and research relating theretoscientific laboratory services; Scientific services and research relating theretoscientific research and scientific research information in the field of pharmaceuticals and clinical trials and conducting clinical trials for others; scientific services and research relating theretoscientific researchscientific research and developmentanalysistestingproviding of scientific research information in the fields of biologychemistry or medicineas well as in the fields of immunologyoncologymolecular biologycellular biologybiochemistry and medicinal chemistry as well as in the fields of discovery and development of pharmaceuticalsmedical and veterinary preparationsdiagnostic preparations and biomarker reagents and diagnostic apparatus; scientific services and research theretoscientific researchscientific research and developmentanalysistestingproviding of scientific research information in the field of discovery of drug targets and drug candidates for the treatment or diagnostics of diseasesdisorders and conditions in humans and animalsin particular in the fields of oncologyinflammatory-autoimmune- and metabolic diseases; providing technical and scientific information about a biotechnology companyits technologiesprojectsproduct-candidatesproducts and services via a web site on a global computer network; design and development of computer software; design and development of computer software for use in the fields of biologychemistry or medicineespecially immunologyoncologymolecular biologycellular biologybiochemistry and/or medicinal chemistryas well as in the fields of discovery and development of pharmaceuticalsmedical and veterinary preparationsdiagnostic preparations and biomarker reagents and diagnostic apparatus.
Publications
History of USPTO decisions and trademark events.
25 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/13/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/12/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/10/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/20/2026
PUBO
PUBLISHED FOR OPPOSITION
01/20/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/14/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/28/2025
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
08/12/2025
RFNT
REFUSAL PROCESSED BY IB
07/12/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/22/2025
RFRR
REFUSAL PROCESSED BY MPU
06/22/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/24/2025
CNRT
NON-FINAL ACTION WRITTEN
04/23/2025
DOCK
ASSIGNED TO EXAMINER
04/15/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
02/14/2025
MAFR
APPLICATION FILING RECEIPT MAILED
12/27/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/27/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/26/2024
Continuous trademark protection
Get notified about every new filing that threatens CYCURIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.